Mild and General One-Pot Reduction and Cyclization of Aromatic and Heteroaromatic 2-Nitroamines to Bicyclic 2H-Imidazoles

Abstract

A one-pot procedure for the conversion of aromatic and heteroaromatic 2-nitroamines into bicyclic 2H-benzimidazoles is described. The procedure employs formic acid, iron powder, and an additive such as NH₄Cl to reduce the nitro group and effect the imidazole cyclization with high-yielding conversions generally within one to two hours. The compatibility with a wide range of functionality demonstrates the general utility of this procedure.

cyclization - heterocycles - imidazole - iron - reduction

References and Notes

1a Horton DA. Bourne GT. Smythe ML. Chem. Rev.  2003,  103:  893 

1b Spasov AA. Yozhitsa IN. Bugaeva LI. Anisimova VA. Pharm. Chem. J.  1999,  33:  232 

2 Ding S. Gray NS. Ding Q. Schultz PG. Tetrahedron Lett.  2001,  42:  8751 

3a Phillips MA. J. Chem. Soc.  1928,  2393 

3b Wright JB. Chem. Rev.  1951,  48:  397 

3c Subasinghe NL. Travins JM. Ali F. Huang H. Ballentine SK. Marugan JJ. Khalil E. Hufnagel HR. Bone RF. Desjarlais RL. Crysler CS. Ninan N. Cummings MD. Molloy CJ. Tomczuk BE. Bioorg. Med. Chem. Lett.  2006,  16:  2200 

3d Minetti P. Tinti MO. Carminati P. Castorina M. Di Cesare MA. Serio SD. Gallo G. Ghirardi O. Giorgi F. Giorgi L. Piersanti G. Bartoccini F. Tarzia G. J. Med. Chem.  2005,  48:  6887 

3e Suzuki N. Tanaka Y. Dohmori R. Chem. Pharm. Bull.  1980,  28:  235 

3f Seley KL. O’Daniel PI. Salim S. Nucleosides, Nucleotides Nucleic Acids  2003,  22:  2133 

3g Maron D. Kontorowitsch M. Bloch J.-J. Ber. Dtsch. Chem. Ges.  1914,  47:  1352 

3h van Galen PJM. Nissen P. van Wijngaarden I. Ijzerman AP. Soudijn W. J. Med. Chem.  1991,  34:  1202 

3i Palmer BD. Smaill JB. Boyd M. Boschelli DH. Doherty AM. Hamby JM. Khatana SS. Kramer JB. Kraker AJ. Panek RL. Lu GH. Dahring TK. Winters RT. Showalter HDH. Denny WA. J. Med. Chem.  1998,  41:  5457 

4a Boydston AJ. Pecinovsky CS. Chao ST. Bielawski CW. J. Am. Chem. Soc.  2007,  129:  14550 

4b Wallace EM, Lyssikatos JP, Marlow AL, and Hurley TB. inventors; US 2003/216460  A1. 

4c Huisgen R. Justus Liebigs Ann. Chem.  1948,  559:  101 

4d Cholody WM. Hernandez L. Hassner L. Scudiero DA. Djurickovic DB. Michejda CJ. J. Med. Chem.  1995,  38:  3043 

4e VanVliet DS. Gillespie P. Scicinski JJ. Tetrahedron Lett.  2005,  46:  6741 

4f Chen JJ. Thakur KD. Clark MP. Laughlin SK. George KM. Bookland RG. Davis JR. Cabrera EJ. Easwaran V. De B. Zhang YG. Bioorg. Med. Chem. Lett.  2006,  16:  5633 

4g Boydston AJ. Khramov DM. Bielawski CW. Tetrahedron Lett.  2006,  47:  5123 

4h Boydston AJ. Vu PD. Dykhno OL. Chang V. Wyatt AR. Stockett AS. Ritschdorff ET. Shear JB. Bielawski CW. J. Am. Chem. Soc.  2008,  130:  3143 

5a Roth T. Morningstar ML. Boyer PL. Hughes SH. Buckheit RW. Michejda CJ. J. Med Chem.  1997,  40:  4199 

5b Nozary H. Piguet C. Tissot P. Bernardinelli G. Bunzli J.-CG. Deschenaux R. Guillon D. J. Am. Chem. Soc.  1998,  120:  12274 

5c Suami T. Day A. J. Org. Chem.  1959,  24:  1340 

5d Piguet C. Bocquet B. Helv. Chim. Acta  1994,  77:  931 

5e McKenzie BM. Miller AK. Wojtecki RJ. Johnson JC. Burke KA. Tzeng KA. Mather PT. Rowan SJ. Tetrahedron  2008,  64:  8488 

6a Radl S. Hradil P. Coll. Czech. Chem. Commun.  1991,  56:  2420 

6b Efremov IV, Rogers BN, Duplantier AJ, Zhang L, Zhang Q, and Maklad NS. inventors; US 2008/0312271  A1. 

7a Wu W.-L. Burnett DA. Spring R. Greenlee WJ. Smith M. Favreau L. Fawzi A. Zhang H. Lachowicz JE. J. Med. Chem.  2005,  48:  680 

7b Burnett DA, and Wu W.-L. inventors; US 2008/312218  A1. 

7c Bounaud P.-Y, Smith CR, and Jefferson EA. inventors; WO 2008/51808  A2. 

7d Foster R. Ing HR. Rogers EF. J. Chem. Soc.  1957,  1671 

7e Bolger J, Castelhano AL, Crew AP, Dong H.-Q, Honda A, Laufer R, Li A.-H, Mulvihill K, Qui L, Sambrook-Smith CP, Sun Y, Wynne GM, and Zhang T. inventors; WO  2005/21531A1. 

7f Crew AP, Cox M, Laufer R, Pegg NA, Smith S, Peter C, Sun Y, Wilkes RD, and Williams J. inventors; US 2006/116402  A1. 

8

The role of the alcohol co-solvent in this reaction is to increase solubilization of the substrate and may be omitted for substrates with good solubility in neat formic acid (unpublished observation).

9

If the reaction is followed by LC-MS at shorter time intervals, the progression from starting material to bisaniline to N-formylated aniline to cyclized product can typically be observed.

10

Analytical Data for Compounds 2-19
1-Ethyl-1 H -benzo[ d ]imidazole ^¹6 (2) ESI-MS: m/z = 147.4 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 8.23 (s, 1 H), 7.62 (dd, J = 18.0, 7.9 Hz, 2 H), 7.22 (dt, J = 15.0, 7.2 Hz, 2 H), 4.28 (q, J = 7.3 Hz, 2 H), 1.41 (t, J = 7.3 Hz, 3 H).
1-Phenyl-1 H -benzo[ d ]imidazole ^¹7 (3)
ESI-MS: m/z = 195.4 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 8.56 (s, 1 H), 7.78 (dd, J = 6.5, 2.3 Hz, 1 H), 7.69 (dd, J = 8.4, 1.1 Hz, 2 H), 7.67-7.60 (m, 3 H), 7.51 (t, J = 7.2 Hz, 1 H), 7.38-7.28 (m, 2 H).
N , N -Dimethyl-1 H -benzo[ d ]imidazol-6-amine (4)
ESI-MS: m/z = 162.4 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.0 (br s, 1 H), 7.96 (s, 1 H), 7.40 (br s, 1 H), 6.78 (d, J = 7.9 Hz, 2 H), 2.88 (s, 6 H).
5-Ethoxy-1 H -benzo[ d ]imidazole ^¹8 (5) ESI-MS: m/z = 163.0 [M + H]⁺. ^¹H NMR (400 MHz, DMSO, reported as a mixture of tautomers): δ = 12.25 (br s, 0.4 H), 12.20 (br s, 0.6 H), 8.10 (br s, 0.4 H), 8.04 (br s, 0.6 H), 7.49 (br d, J = 8.8 Hz, 0.6 H), 7.38 (br d, J = 8.2 Hz, 0.4 H), 7.14 (br s, 0.4 H), 6.98 (br s, 0.6 H), 6.83-6.77 (m, 1 H), 4.03 (q, J = 6.9 Hz, 2 H), 1.34 (t, J = 6.9 Hz, 3 H).
1 H -Benzo[ d ]imidazole-5-carbonitrile ^¹9 (6)
ESI-MS: m/z = 144.4 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.96 (s, 1 H), 8.47 (s, 1 H), 8.16 (s, 1 H), 7.76 (d, J = 8.0 Hz, 1 H), 7.59 (d, J = 8.1 Hz, 1 H).
5-Chloro-1 H -benzo[ d ]imidazole ^²0 (7) ESI-MS: m/z = 152.9 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.60 (s, 1 H), 8.27 (s, 1 H), 7.62 (m, 2 H), 7.22 (d, J = 7.7 Hz, 1 H).
4-Chloro-1 H -benzo[ d ]imidazole ^²¹ (8)
ESI-MS: m/z = 153.4 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 8.31 (s, 1 H), 7.55 (d, J = 7.9 Hz, 1 H), 7.30-7.05 (m, 2 H).
5-Iodo-1 H -benzo[ d ]imidazole ^²² (9)
ESI-MS: m/z = 244.9 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.52 (br s, 1 H), 8.19 (s, 1 H), 7.95 (s, 1 H), 7.47 (dd, J = 8.4, 1.4 Hz, 1 H), 7.43 (d, J = 8.4 Hz, 1 H).
Methyl 1 H -Benzo[ d ]imidazole-7-carboxylate ^²³ (10)
ESI-MS: m/z = 177.3 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.56 (s, 1 H), 8.31 (s, 1 H), 7.97 (d, J = 8.0 Hz, 1 H), 7.86 (d, J = 7.6 Hz, 1 H), 7.32 (t, J = 7.8 Hz, 1 H), 3.95 (s, 3 H).
1 H -Benzo[ d ]imidazol-5-ol ^²4 (11)
ESI-MS: m/z = 135.4 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.21 (br s, 1 H), 9.08 (s, 1 H), 8.03 (s, 1 H), 7.37 (d, J = 8.6 Hz, 1 H), 6.87 (s, 1 H), 6.68 (d, J = 8.5 Hz, 1 H).
5-(Allyloxy)-1 H -benzo[ d ]imidazole (12)
ESI-MS: m/z = 175.4 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.25 (s, 1 H), 8.08 (s, 1 H), 7.45 (s, 1 H), 7.08 (s, 1 H), 6.83 (dd, J = 8.7, 2.0 Hz, 1 H), 6.07 (ddt, J = 17.2, 10.5, 5.2 Hz, 1 H), 5.41 (ddd, J = 17.3, 3.4, 1.6 Hz, 1 H), 5.26 (dd, J = 10.5, 1.5 Hz, 1 H), 4.61-4.54 (m, 2 H).
5-(Triisopropylsilyloxy)-1 H -benzo[ d ]imidazole (13)
ESI-MS: m/z = 291.4 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.17 (s, 1 H), 8.09 (s, 1 H), 7.43 (s, 1 H), 6.99 (s, 1 H), 6.76 (d, J = 8.9 Hz, 1 H), 1.25 (dd, J = 14.9, 7.2 Hz, 3 H), 1.07 (d, J = 7.4 Hz, 18 H).
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1 H -benzo[ d ]imidazole (14)
ESI-MS: m/z = 245.4 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.48 (s, 1 H), 8.24 (s, 1 H), 7.90 (s, 1 H), 7.57 (s, 1 H), 7.50 (d, 1 H), 1.31 (s, 12 H).
3 H -Imidazo[4,5- f ]quinoline ^²5 (15)
ESI-MS: m/z = 169.9 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 13.51 (br s, 0.5 H), 12.94 (br s, 0.5 H), 8.86-8.85 (m, 1 H), 8.78 (br s, 1 H), 8.38 (br s, 1 H), 7.97 (br d, J = 7.8 Hz, 1 H), 7.81 (d, J = 8.9 Hz, 1 H), 7.61 (dd, J = 8.3, 4.3 Hz, 1 H).
3-{1 H -Benzo[ d ]imidazol-5-yl}-3 H -imidazo[4,5- b ]pyridine (16)
ESI-MS: m/z = 250.2 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 12.72 (s, 1 H), 8.83 (s, 1 H), 8.36 (s, 1 H), 8.28 (s, 1 H), 8.13 (s, 1 H), 8.02 (s, 1 H), 7.85-7.60 (m, 2 H), 2.46 (s, 3 H).
6-Bromo-7-methyl-3 H -imidazo[4,5- b ]pyridine ^²6 (17)
ESI-MS: m/z = 211.9 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 8.42 (s, 1 H), 8.40 (s, 1 H), 2.60 (s, 3 H).
6-Phenyl-1 H -imidazo[4,5- c ]pyridine (18)
ESI-MS: m/z = 196.3 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 9.00 (s, 1 H), 8.40 (s, 1 H), 8.16-8.06 (m, 3 H), 7.53-7.43 (m, 2 H), 7.43-7.34 (m, 1 H).
6-Chloro-1 H -imidazo[4,5- c ]pyridine ^²7 (19)
ESI-MS: m/z = 153.8 [M + H]⁺. ^¹H NMR (400 MHz, DMSO): δ = 8.74 (s, 1 H), 8.45 (s, 1 H), 7.67 (s, 1 H).

Bongartz J.-P, Andre M, Meerpoel L, Boeckx GM, Van Lommen G, Buyck C, Obrecht D, Ermert P, and Luther A. inventors; WO 2008/148840  A1. (a)

(b) Popil’nichenko SV. Brovarets BS. Drach BS. Russ. J. Org. Chem.  2004,  40:  219 

11a FeCl₂ has been reported to reductively cleave isoxazoles: Auricchio S. Bini A. Pastormerlo E. Truscello AM. Tetrahedron  1997,  53:  10911 

11b Nitro-isoxazoles have been reported to undergo acid-catalyzed thermal isomerization and hydrolysis: Pinho e Melo TMVD. Curr. Org. Chem.  2005,  9:  925 

12a Krasovskiy A. Malakhov V. Gavryushin A. Knochel P. Angew. Chem. Int. Ed.  2006,  45:  6040 

12b Krasovskiy A. Knochel P. Angew. Chem. Int. Ed.  2004,  43:  3333 

12c Wunderlich SH. Knochel P. Angew. Chem. Int. Ed.  2009,  48:  9717 

13 Piller FM. Appukkuttan P. Gavryushin A. Helm M. Knochel P. Angew. Chem. Int. Ed.  2008,  47:  6802 

14 Wundt E. Ber. Dtsch. Chem. Ges.  1878,  11:  826 

15 v. Auwers K. Maws W. Ber. Dtsch. Chem. Ges.  1928,  61:  2415 

16 Fischer O. Rigaud M. Ber. Dtsch. Chem. Ges.  1901,  34:  4204 

17 Sekikawa I. Bull. Chem. Soc. Jpn.  1958,  31:  252 

18 Van Vliet DS. Gillespie P. Scicinski JJ. Tetrahedron Lett.  2005,  46:  6741 

19 Fischer O. Ber. Dtsch. Chem. Ges.  1904,  37:  557 

20 Rabiger DJ. Joullie MM. J. Chem. Soc.  1964,  915 

21 Rabiger DJ. Joullie MM. J. Org. Chem.  1961,  26:  1649 

22 Howell JR. Rasmussen M. Austr. J. Chem.  1993,  46:  1177 

23 Robinson FM. Miller IM. McPherson JF. Folkers K. J. Am. Chem. Soc.  1955,  77:  5192 

24 Weidenhagen R. Weeden U. Ber. Dtsch. Chem. Ges.  1938,  71:  2347 

25 Graboyes H. Day AR. J. Am. Chem. Soc.  1957,  79:  6421 

26 Rousseau RJ. Robins RK. J. Heterocycl. Chem.  1965,  2:  196